DK489581A - Praeparat til terapeutisk eller diagnostisk anvendelse og fremgangsmaade til terapeutisk behandling - Google Patents

Praeparat til terapeutisk eller diagnostisk anvendelse og fremgangsmaade til terapeutisk behandling

Info

Publication number
DK489581A
DK489581A DK489581A DK489581A DK489581A DK 489581 A DK489581 A DK 489581A DK 489581 A DK489581 A DK 489581A DK 489581 A DK489581 A DK 489581A DK 489581 A DK489581 A DK 489581A
Authority
DK
Denmark
Prior art keywords
therapeutic
structural element
mammals including
including man
antibodies
Prior art date
Application number
DK489581A
Other languages
Danish (da)
English (en)
Inventor
G P Kaellenius
K A Lundblad
N R Moellby
S B Svensson
J Winberg
Original Assignee
G P Kaellenius
K A Lundblad
N R Moellby
S B Svensson
J Winberg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by G P Kaellenius, K A Lundblad, N R Moellby, S B Svensson, J Winberg filed Critical G P Kaellenius
Publication of DK489581A publication Critical patent/DK489581A/da

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54353—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals with ligand attached to the carrier via a chemical coupling agent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A61K35/18—Erythrocytes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H3/00—Compounds containing only hydrogen atoms and saccharide radicals having only carbon, hydrogen, and oxygen atoms
    • C07H3/06—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/24—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
    • C07K14/245—Escherichia (G)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1203—Gram-negative bacteria
    • C07K16/1228—Enterobacterales (O), e.g. Citrobacter (G), Serratia (G), Proteus (G), Providencia (G), Morganella (G) or Yersinia (G)
    • C07K16/1232—Escherichia (G)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/544—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being organic
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Urology & Nephrology (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Virology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Public Health (AREA)
  • Developmental Biology & Embryology (AREA)
  • Zoology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Saccharide Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
DK489581A 1980-03-05 1981-11-04 Praeparat til terapeutisk eller diagnostisk anvendelse og fremgangsmaade til terapeutisk behandling DK489581A (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE8001748A SE8001748L (sv) 1980-03-05 1980-03-05 Kompositioner for terapeutisk eller diagnostisk anvendning jemte forfarande for terapeutik
PCT/SE1981/000065 WO1981002520A1 (en) 1980-03-05 1981-03-05 Compositions for therapeutic or diagnostic use in connection with bacterial infections,and their use

Publications (1)

Publication Number Publication Date
DK489581A true DK489581A (da) 1981-11-04

Family

ID=20340427

Family Applications (2)

Application Number Title Priority Date Filing Date
DK489581A DK489581A (da) 1980-03-05 1981-11-04 Praeparat til terapeutisk eller diagnostisk anvendelse og fremgangsmaade til terapeutisk behandling
DK075787A DK75787D0 (da) 1980-03-05 1987-02-13 Praeparat til terapeutisk eller diagnostisk anvendelse og fremgangsmaade til terapeutisk behandling

Family Applications After (1)

Application Number Title Priority Date Filing Date
DK075787A DK75787D0 (da) 1980-03-05 1987-02-13 Praeparat til terapeutisk eller diagnostisk anvendelse og fremgangsmaade til terapeutisk behandling

Country Status (10)

Country Link
US (2) US4657849A (de)
EP (1) EP0035484B1 (de)
JP (1) JPH0322397B2 (de)
AT (1) ATE9062T1 (de)
AU (1) AU546148B2 (de)
DE (1) DE3165623D1 (de)
DK (2) DK489581A (de)
FI (1) FI71432C (de)
SE (1) SE8001748L (de)
WO (1) WO1981002520A1 (de)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0058665B1 (de) * 1980-05-09 1986-02-26 LEFFLER, Hakon Carbohydrat-derivate zum hemmen eines bakteriellen anhaftens
US4521592A (en) * 1981-10-23 1985-06-04 Svenska Sockerfabriks Ab Compounds for therapeutic or diagnostic use, a process and intermediates for their preparation
AU561067B2 (en) * 1982-03-22 1987-04-30 Biocarb Ab Anti-bacterial composition containing an oligosaccharide
AU561066B2 (en) * 1982-03-22 1987-04-30 Biocarb Ab Antibacterial composition containing an oligosaccharide
EP0089940A1 (de) * 1982-03-23 1983-09-28 BioCarp AB Oligosaccharide umfassende Zusammensetzung für therapeutische oder diagnostische Verwendung
SE8301609D0 (sv) * 1983-03-23 1983-03-23 Svenska Sockerfabriks Ab Forening och komposition for terapeutisk eller diagnostisk anvendning jemte forfarande for terapeutisk behandling
SE8304006D0 (sv) * 1983-07-15 1983-07-15 Karlsson Karl Anders Forening och komposition for terapeutisk eller diagnostisk anvendning samt forfarande for terapeutisk behandling
SE8304007D0 (sv) * 1983-07-15 1983-07-15 Karlsson Karl Anders Forening och komposition for terapeutisk eller diagnostisk anvendning samt forfarande for terapeutisk behandling
DE3402739A1 (de) * 1984-01-27 1985-08-01 Boehringer Ingelheim Diagnostika GmbH, 8046 Garching Antikoerper gegen den glycanstrang des peptidoglycans, verfahren und reagenzien zu ihrer herstellung und methoden zu ihrer quantitativen bestimmung
DK219084D0 (da) * 1984-05-02 1984-05-02 Frederik Carl Peter Lindberg Antigen
SE8406626D0 (sv) * 1984-12-27 1984-12-27 Bio Carb Ab Forening och komposition for terapeutisk eller diagnostisk anvendning jemte anvendning av sadan forening och komposition for terapeutisk behandling och isolering av shigatoxin
IL76981A (en) * 1985-11-07 1989-02-28 Univ Ramot Bacterially produced hetero polysaccharide dispersants for inorganic minerals in aqueous medium and their preparation
US5324828A (en) * 1986-12-11 1994-06-28 Genzyme Corporation 1-amino-1-deoxyoligosaccharides and derivatives thereof
US4942224A (en) * 1987-01-12 1990-07-17 The Biomembrane Institute A-associated H-antigens, monoclonal antibodies specific thereto and methods for employing the same in blood typing
US4857639A (en) * 1987-01-12 1989-08-15 The Biomembrane Institute A-associated H-antigens, monoclonal antibodies specific thereto and methods for employing the same in blood typing
US5112770A (en) * 1988-06-08 1992-05-12 North Carolina State University Precipitation of multivalent antiligands with affinity surfactants
US5167925A (en) * 1988-06-08 1992-12-01 North Carolina State University Precipitation of multivalent antiligands with affinity surfactants
US5164298A (en) * 1988-06-24 1992-11-17 Hsc Research Development Corporation Verocytotoxin receptor assay
US5217715A (en) * 1988-08-01 1993-06-08 The United States Of America As Represented By The Department Of Health And Human Services Carbohydrate receptor for bacteria and method for use thereof
US5089479A (en) * 1988-11-28 1992-02-18 Krivan Howard C Adhesion of mycoplasma pneumoniae and mycoplasma hominus to sulfatide
DK455088D0 (da) * 1988-08-12 1988-08-12 Symbicom Ab Syntetiske receptoranaloger
AU7153991A (en) * 1989-12-13 1991-07-18 Glycomed Incorporated Synthesis of rotavirus receptor saccharides
AU6902691A (en) * 1989-12-13 1991-07-18 Glycomed Incorporated Synthetic receptor molecules recognizable by a rotavirus
US5466681A (en) * 1990-02-23 1995-11-14 Microcarb, Inc. Receptor conjugates for targeting penicillin antibiotics to bacteria
CA2095642C (en) * 1990-08-02 1999-12-14 Howard C. Krivan Adhesion receptors for pathogenic or opportunistic microorganisms
SE9003222L (sv) * 1990-10-10 1992-04-11 Jens Sandros Preparat foer profylaktiskt,terapeutiskt och diagnostiskt bruk vid infektioner
FR2671100B1 (fr) * 1990-12-28 1993-03-05 Bio Merieux Procede d'analyse bacteriologique, et milieu de detection des bacteries genre salmonella.
ES2150888T1 (es) * 1991-10-18 2000-12-16 Synsorb Biotech Inc Diagnosis y tratamiento de la disenteria bacteriana.
JPH09501044A (ja) * 1993-05-14 1997-02-04 ジ・アップジョン・カンパニー ＵＤＰ−ＧＡＬＮＡｃ：ポリペプチド、Ｎ−アセチルガラクトサミニルトランスフェラーゼをコードするクローン化されたＤＮＡ
US5910570A (en) * 1995-11-13 1999-06-08 Pharmacia & Upjohn Company Cloned DNA encoding a UDP-GalNAc: polypeptide N-acetylgalactosaminy-ltransferase
US6096725A (en) * 1997-07-02 2000-08-01 Neose Technologies, Inc. Methods of using αGal oligosaccharides as immune system targeting agents
WO1999052561A1 (en) * 1998-04-15 1999-10-21 Baxter International Inc. Inhibition of xenoreactive antibodies
JP3772204B2 (ja) * 2000-06-05 2006-05-10 独立行政法人産業技術総合研究所 糖鎖誘導体及びその製造方法
US7238677B2 (en) * 2003-03-28 2007-07-03 Kimberly-Clark Worldwide, Inc. Prevention of urogenital infections
US20050095219A1 (en) * 2003-10-29 2005-05-05 Shu-Ping Yang Compositions for promoting vaginal cell proliferation and maturation

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL6903238A (de) * 1968-03-04 1969-09-08
US4125492A (en) * 1974-05-31 1978-11-14 Pedro Cuatrecasas Affinity chromatography of vibrio cholerae enterotoxin-ganglioside polysaccharide and the biological effects of ganglioside-containing soluble polymers
GB1544908A (en) * 1975-07-08 1979-04-25 Chembiomed Ltd Artificial oligosaccharide antigenic determinants
FR2422681A1 (fr) * 1978-04-10 1979-11-09 Anvar Procede de preparation de derives d'osides, les nouveaux derives d'osides obtenus et leurs applications biologiques

Also Published As

Publication number Publication date
EP0035484A3 (en) 1981-09-16
US4657849A (en) 1987-04-14
FI71432C (fi) 1986-12-19
JPS57500194A (de) 1982-02-04
ATE9062T1 (de) 1984-09-15
JPH0322397B2 (de) 1991-03-26
DK75787A (da) 1987-02-13
US4762824A (en) 1988-08-09
EP0035484B1 (de) 1984-08-22
DK75787D0 (da) 1987-02-13
WO1981002520A1 (en) 1981-09-17
DE3165623D1 (en) 1984-09-27
EP0035484A2 (de) 1981-09-09
AU546148B2 (en) 1985-08-15
FI814230L (fi) 1981-12-31
SE8001748L (sv) 1981-09-06
AU6779581A (en) 1981-09-23
FI71432B (fi) 1986-09-09

Similar Documents

Publication Publication Date Title
DK75787A (da) Praeparat til terapeutisk eller diagnostisk anvendelse og fremgangsmaade til terapeutisk behandling
DK609985A (da) Adhesin-antigener, antistoffer mod disse og dna-fragmenter, som indkoder antigenerne
JPH01157387A (ja) ヘモフィラス・インフルエンザワクチン
DK346783A (da) Triphenylimidazolyloxyalkansyrer og derivater deraf, fremgangsmaade til fremstilling deraf og farmaceutiske praeparater indeholdende disse forbindelser
ATE245699T1 (de) Rekombinant pgp3, verfahren zu dessen herstellung,und dessen verwendung in der diagnose und therapie
EP0692031A4 (de) Heterologe antigene in stämmen zur impfung mit lebendzellen
DK505983A (da) Imidazolylalkylthienyl-tetrahydropyridaziner og fremgangsmaade til fremstilling deraf
ES2130121T3 (es) Antigeno intra-acrosomico de esperma humano para uso en una vacuna anticonceptiva.
ES487046A1 (es) Procedimiento de preparacion de proteoglicanos membranarios bacterianos purificados
DK208987D0 (da) Polypeptider og antistoffer, som er karakteristiske for papillomvirus, og deres anvendelse ved diagnostiske metoder og i vacciner
ATE16406T1 (de) Verfahren zur herstellung von isomaltulose (6-o- alpha-d-gluco-pyranosido-d-fructose) mit hilfe von immobilisierten bakterienzellen.
DK311485A (da) Fremgangsmaade til fremstilling af ikke-toksisk lt-b-underenhed i e. coli-enterotoksin
WO1998006850A1 (de) Immunologisch aktive proteine von borrelia burgdorferi, dafür kodierende nukleinsäuren sowie deren verwendung in testkits und als impfstoffe
KR900004935A (ko) 슈도 모나즈 아에루기노사의 지질단백질 i(ompi)
PT74470B (de) Chemische verbindungen verfahren zu ihrer herstellung und ihre verwendungen als antigene oder immunadsorbentien
EP0663404B1 (de) Antikörper für den Nachweis von Salmonellen
DE69734893T2 (de) Rekombinante fusionsproteine des reproduktiven und respiratorischen syndrom virus aus dem schwein (prrsv) und deren verwendung in der diagnose
Drucker et al. Electrophoretic and immunological differences between the cytochrome c 3 of Desulfovibrio desulfuricans and that of Desulfovibrio vulgaris
Sawada et al. Evidence for uptake of basement membrane by differentiating ameloblasts in the rat incisor enamel organ
EP1238280A2 (de) Mittel und verfahren zur diagnose von lyme borreliose sowie borreliose-impfstoff
Castermans et al. Transplantation immunity: separation of antigenic components from isolated nuclei
ATE7700T1 (de) 2-hydroxy-1,2,4-butantricarbonsaeure-oligoribosi - derivate, verfahren zu ihrer herstellung und ihre verwendung als prophylaktische mittel gegen zahnkaries.
RU93020806A (ru) Способ получения антибруцеллезной сыворотки
ATE17083T1 (de) Entgiftetes nervengift aus e-coli, verfahren zu dessen herstellung und dasselbe enthaltende immunologische zusammensetzungen.
Bragg Characterization of fimbriae of Actinomyces naeslundii N16 using monoclonal and polyclonal antibodies

Legal Events

Date Code Title Description
AHS Application shelved for other reasons than non-payment